United States Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-states
United States Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-10-26: 10Y at 5.79%, fitted curve 1M–75Y (4.76%–6.19%), 554 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.76% | — |
| 3M | 4.79% | 4.80% |
| 6M | 4.82% | 4.97% |
| 9M | 4.85% | 5.02% |
| 12M | 4.89% | 5.02% |
| 18M | 4.96% | 5.18% |
| 2Y | 5.04% | 5.35% |
| 3Y | 5.19% | 5.60% |
| 4Y | 5.32% | 5.82% |
| 5Y | 5.40% | 5.89% |
| 6Y | 5.48% | 6.03% |
| 7Y | 5.57% | 6.28% |
| 8Y | 5.65% | 6.49% |
| 9Y | 5.72% | 6.63% |
| 10Y | 5.79% | 6.73% |
| 15Y | 6.02% | 6.86% |
| 20Y | 6.12% | 6.83% |
| 25Y | 6.16% | 6.68% |
| 30Y | 6.18% | 6.54% |
| 40Y | 6.19% | 6.40% |
| 75Y | 6.19% | 6.30% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 5.04% and the 10-year 5.79%, a 10Y−2Y spread of +75 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 5.04% | 5.29% | 4.66% | 4.76% | 4.56% | 4.57% | 4.41% |
| 10Y | 5.79% | 5.91% | 5.50% | 5.50% | 5.11% | 5.19% | 5.19% |
| 10Y − 2Y | +75 bp | +62 bp | +84 bp | +74 bp | +55 bp | +62 bp | +78 bp |
Yields by rating group
The same curve split by credit quality: 579 rated bonds across 2 rating bands, all maturities pooled. Median yield by band: AAA to AA- 5.37%, A+ to BBB- 5.68%.
Bonds in this curve
A selection of 30 of the 579 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Abbott | 4.67% | 2026-11-30 | 3.75% | US002824BF69 |
| Thermo Fisher | 4.89% | 2026-12-05 | 5.00% | US883556CZ38 |
| ELI Lilly | 4.39% | 2027-02-09 | 4.50% | US532457CJ56 |
| Amgen INC | 4.95% | 2027-02-21 | 2.20% | US031162CT53 |
| BIO-RAD Laboratories INC | 4.96% | 2027-03-15 | 3.30% | US090572AR99 |
| ELI Lilly | 4.59% | 2027-03-15 | 5.50% | US532457AZ17 |
| Merck | 4.77% | 2027-06-10 | 1.70% | US58933YBC84 |
| Cardinal Health | 4.77% | 2027-06-15 | 3.41% | US14149YBJ64 |
| Zoetis | 4.94% | 2027-09-12 | 3.00% | US98978VAL71 |
| Merck | 4.62% | 2027-09-15 | 3.85% | US58933YBP97 |
| Abbott | 4.78% | 2028-01-30 | 1.15% | US002824BP42 |
| ELI Lilly | 4.62% | 2028-02-12 | 4.55% | US532457CU02 |
| Amgen INC | 5.07% | 2028-08-15 | 1.65% | US031162DB37 |
| EMD Finance | 5.06% | 2028-08-15 | 4.12% | US26867LAN01 |
| Johnson & Johnson | 4.74% | 2029-06-01 | 4.80% | US478160CU63 |
| Gilead | 5.10% | 2029-05-20 | 4.40% | US375558CK71 |
| Biogen | 5.38% | 2030-05-01 | 2.25% | US09062XAH61 |
| Cencora | 5.38% | 2030-05-15 | 2.80% | US03073EAR62 |
| HCA INC | 5.52% | 2031-05-15 | 4.70% | US404119DJ57 |
| Mckesson | 5.42% | 2032-05-30 | 4.95% | US581557BX22 |
| HCA INC | 5.74% | 2033-05-15 | 5.00% | US404119DK21 |
| Gilead | 5.49% | 2034-05-20 | 4.90% | US375558CM38 |
| Abbvie | 5.62% | 2035-05-14 | 4.50% | US00287YAR09 |
| HCA INC | 6.34% | 2036-07-15 | 7.75% | US19767QAS49 |
| Amgen INC | 6.00% | 2041-08-15 | 2.80% | US031162DA53 |
| Celgene | 6.48% | 2044-05-15 | 4.62% | US151020AM68 |
| CVS Health | 6.38% | 2050-04-01 | 4.25% | US126650DL16 |
| Solventum | 6.47% | 2054-04-30 | 5.90% | US83444MAS08 |
| Merck | 6.07% | 2061-12-10 | 2.90% | US58933YBG98 |
| HCA INC | 7.39% | 2095-11-15 | 7.50% | US197677AH07 |